Attention-Deficit Hyperactivity Disorder. Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention group: The rTMS intervention will be administered to the right prefrontal cortex at 120% of the motor threshold, with a frequency of 18 Hz. Each session will consist of 40 trains, each la
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) based on DSM-5 Diagnostic Criteria Ages older than 18 and younger than 40 years old Fluency in Farsi language
Exclusion criteria
Exclusion criteria: Age less than 18 years and greater than 40 years Having other psychiatric disorders except for simple phobia and nicotine dependency High risk of suicide attempt Pychosis Consumption of antipsychotic drugs, antidepressants, or mood stabilizers History of epilepsy in oneself or first-degree relatives Severe neurological disorder or physical problems Those who cannot tolerate rTMS stimulation Consumption of seizure threshold-lowering medications Presence of magnetic device or metal shrapnel in the head, and cardiac pacemaker Pregnancy Individuals lacking the capacity to give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rapid visual processing test score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: rapid visual processing test.;Spatial working memory (SWM) test score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: spatial working memory (SWM) test.;Stocking of Cambridge (SOC) test score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: stocking of Cambridge (SOC) test.;Stop signal task (SST) test score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: stop signal task (SST) test.;Spatial span (SSP) test score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: spatial span (SSP) test.;Integrated Visual and Auditory (IVA2) test score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: Integrated Visual and Auditory (IVA2) test.;Conners Questionnaire Score. Timepoint: Before the intervention, 21 days and 51 days after rTMS treatment. Method of measurement: Conners Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: During and following the intervention. Method of measurement: Clinical examination and patient questioning. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParisa Pishravian
Tehran University of Medical Sciences
Outcome results
None listed